4crl: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
m Protected "4crl" [edit=sysop:move=sysop]
OCA (talk | contribs)
No edit summary
Line 6: Line 6:


Description: Specific inhibition of Mediator kinases as a therapeutic approach for acute myeloid leukaemia
Description: Specific inhibition of Mediator kinases as a therapeutic approach for acute myeloid leukaemia
[[Category: Unreleased Structures]]
[[Category: Si, C]]
[[Category: Banka, D]]
[[Category: Arefolov, A]]
[[Category: Tangpeerachaikul, A]]
[[Category: Poss, Z.C]]
[[Category: Shair, M.D]]
[[Category: Liau, B.B]]
[[Category: Mapa, F.A]]
[[Category: Caruso, B.T]]
[[Category: Pelish, H.E]]
[[Category: Nordin, B.E]]
[[Category: Flyer, A.N]]
[[Category: Wilson, C.J]]
[[Category: Schneider, E.V]]
[[Category: Lemieux, M.E]]
[[Category: Krivtsov, A]]
[[Category: Kung, A.L]]
[[Category: Zou, G]]
[[Category: Kohl, N.E]]
[[Category: Armstrong, S.A]]
[[Category: Patricelli, M.P]]
[[Category: Jestel, A]]
[[Category: Fadeyi, O]]
[[Category: Taatjes, D.J]]
[[Category: Du, K]]
[[Category: Dasilva, D.H]]
[[Category: Christie, A.L]]
[[Category: Myers, A.G]]
[[Category: Bronson, R.T]]

Revision as of 13:28, 24 December 2014

Unreleased structure

The entry 4crl is ON HOLD

Authors: Pelish, H.E., Liau, B.B., Tangpeerachaikul, A., Poss, Z.C., DaSilva, D.H., Caruso, B.T., Arefolov, A., Fadeyi, O., Christie, A.L., Du, K., Banka, D., Schneider, E.V., Jestel, A., Wilson, C.J., Mapa, F.A., Flyer, A.N., Nordin, B.E., Zou, G., Si, C., Bronson, R.T., Patricelli, M.P., Krivtsov, A., Myers, A.G., Kohl, N.E., Kung, A.L., Armstrong, S.A., Lemieux, M.E., Taatjes, D.J., Shair, M.D.

Description: Specific inhibition of Mediator kinases as a therapeutic approach for acute myeloid leukaemia

Proteopedia Page Contributors and Editors (what is this?)

OCA